|
Prac-tic
|
275 mg
|
EU/2/06/066/009
|
Elanco GmbH, Vācija
|
QP53AX26
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Pyriprole
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
16-Nov-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/066/009 |
275 mg/deva |
30 |
Pipete, 1 deva |
-
|
|
|
EVICTO
|
240 mg
|
EU/2/19/242/020
|
VIRBAC, Francija
|
QP54AA05
|
dogs 20,1–40,0 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/020 |
120 mg/ml |
4 |
Polipropilēna pipete, 2 ml |
-
|
|
|
Emevet
|
-
|
EU/2/25/343/005
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/343/005 |
|
1 |
Blisteris, 10 tablete |
-
|
|
|
NexGard
|
136.0 mg/tabl.
|
EU/2/13/159/011
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
MERIAL, Francija
|
| Date of authorisation/renewal: |
13-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/159/011 |
136 mg/tabl. |
1 |
PVH/Aclar/Al blisteris, 3 tablete |
-
|
|
|
Zenalpha
|
-
|
EU/2/21/279/002
|
Vetcare Oy, Somija
|
QN05CM99
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Medetomidine hydrohloride, Vatinoxan hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Apotek Produktion & Laboratorier AB, Zviedrija
|
| Date of authorisation/renewal: |
15-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/279/002 |
|
5 |
Stikla flakons, 10 ml |
-
|
|
|
Clevor
|
30 mg/ml
|
EU/2/17/222/007
|
Orion Corporation, Somija
|
QN04BC04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
eye drops, solution
|
| International name (active substance): |
Ropinirole hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation, Somija
|
| Date of authorisation/renewal: |
09-Mar-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/222/007 |
30 mg/ml |
10 |
ZBPE flakons, 0,6 ml |
-
|
|
|
Coxevac
|
-
|
EU/2/10/110/002
|
Ceva Sante Animale., Francija
|
QI02AB
|
cattle; goats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated Coxiella burnetti
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
29-Sep-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/110/002 |
|
1 |
Plastmasas pudele, 100 ml |
-
|
|
|
Credelio Plus
|
-
|
EU/2/21/271/013
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
14-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/271/013 |
|
1 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/008
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 5-10 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/008 |
|
3 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Coliprotec F4/F18
|
-
|
EU/2/16/202/003
|
Elanco GmbH, Vācija
|
QI09AE03
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oral suspension
|
| International name (active substance): |
Live non-pathogenic Escherichia coli O8:K87 (F4ac),Live non-pathogenic Escherichia coli O141:K94 (F18ac)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lohmann Animal Health GmbH , Vācija;Klifovet AG , Vācija
|
| Date of authorisation/renewal: |
11-Nov-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/16/202/003 |
|
4 |
Stikla flakons, 50 deva |
-
|
|
|
PG 600
|
-
|
V/I/23/0058
|
Intervet International B.V., Nīderlande
|
QG03GA99
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder and solvent for solution for injection
|
| International name (active substance): |
Human chorionic gonadotrophin, Gonadotropinum sericum equinum
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande;Intervet International GmbH, Vācija
|
| Date of authorisation/renewal: |
08-Nov-2023
|
| Marketing authorisation valid until: |
07-Nov-2028
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 08112023LI (08-Nov-2023)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/23/0058-01 |
|
1 |
Flakons, 5 devas/flakonā |
[PDF]
[PDF]
|
|
|
NEXGARD SPECTRA
|
-
|
EU/2/14/177/008
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Milbemycin oxime,Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
15-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/177/008 |
|
1 |
PVH/Aclar/Al blisteris, 3 tablete |
-
|
|
|
Dexdomitor
|
0.1 mg/ml
|
EU/2/02/033/004
|
Orion Corporation, Somija
|
QN05CM18
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dexmedetomidine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation Fermion, Somija
|
| Date of authorisation/renewal: |
30-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/02/033/004 |
0,1 mg/ml |
10 |
Stikla flakons, 20 ml |
-
|
|
|
Sedachem
|
20 mg/ml
|
V/I/24/0009
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QN05CM92
|
cattle; horses; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Xylazine hydrochloride
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
| Date of authorisation/renewal: |
18-Jan-2024
|
| Marketing authorisation valid until: |
17-Jan-2029
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 02102025 (02-Oct-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/24/0009-01 |
20 mg/ml |
1 |
Stikla pudele, 50 ml |
[PDF]
[PDF]
[PDF]
|
|
|
Bovela
|
-
|
EU/2/14/176/013
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI02AD02
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health USA Inc., ASV
|
| Date of authorisation/renewal: |
21-Dec-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/176/013 |
|
1 |
Stikla flakons, 50 deva |
-
|
|
|
Onsior
|
5 mg
|
EU/2/08/089/005
|
Elanco GmbH, Vācija
|
QM01AH91
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Robenacoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
|
| Date of authorisation/renewal: |
15-Dec-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/089/005 |
5 mg/tabl. |
14 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/017
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 40-60 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/017 |
|
3 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
NEXGARD SPECTRA
|
-
|
EU/2/14/177/015
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Milbemycin oxime,Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
15-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/177/015 |
|
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
REXXOLIDE
|
100 mg/ml
|
EU/2/20/263/001
|
Dechra Regulatory B.V., Nīderlande
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/263/001 |
100 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
APOQUEL
|
16 mg/tabl.
|
EU/2/13/154/017
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Italia S.R.L., Itālija
|
| Date of authorisation/renewal: |
26-Jul-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/017 |
16 mg/tabl. |
1 |
ABPE pudelīte, 50 tablete |
-
|
|